For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251105:nRSE3192Ga&default-theme=true
RNS Number : 3192G Antofagasta PLC 05 November 2025
Site Visit
Centinela Second Concentrator
Antofagasta plc ("Antofagasta", or the "Company") is hosting an investor and
analyst site tour on 5 November and 6 November 2025, at the Centinela Second
Concentrator Project.
As previously announced, the project remains on track and on budget.
During the tour, the Antofagasta team will provide insights on the Company's
strategy, how it is being delivered safely and responsibly, and how innovation
and technology are being used to drive performance.
The presentation materials will be made available during the course of the
visit on the Company's website (https://www.antofagasta.co.uk
(https://www.antofagasta.co.uk) ), including a video showing the current
progress at the Second Concentrator project, which can be viewed here
(https://www.antofagasta.co.uk/media/video-library/) .
Antofagasta announced its Q3 2025 Production Report including guidance for
full-year 2026 production on 23 October 2025.
Investors - London
Media - London
Rosario Orchard rorchard@antofagasta.co.uk
(mailto:rorchard@antofagasta.co.uk) Sara
Powell antofagasta@fticonsulting.com
(file:///C%3A/Users/bbrewe1/AppData/Local/Microsoft/Windows/INetCache/Content.Outlook/KZEYLDBW/antofagasta@fticonsulting.com)
Robert Simmons rsimmons@antofagasta.co.uk
(mailto:rsimmons@antofagasta.co.uk) Ben
Brewerton
Telephone +44 20 7808 0988
Nick Hennis
Telephone +44 20 3727 1000
Media - Santiago
Pablo Orozco
porozco@aminerals.cl (mailto:porozco@aminerals.cl)
Carolina Pica cpica@aminerals.cl
(mailto:cpica@aminerals.cl)
Telephone +56 2 2798 7000
Register on our website to receive our email alerts at the following address:
https://www.antofagasta.co.uk/investors/news/email-alerts/
(https://www.antofagasta.co.uk/investors/news/email-alerts/)
________________________________________________________________________________________
Cautionary Statement
This announcement may contain certain forward-looking statements. All
statements other than statements of historical fact are, or may be deemed to
be, forward-looking statements.
These forward-looking statements are based upon current expectations and
assumptions regarding anticipated developments and other factors affecting the
Group. They are not historical facts, nor are they guarantees of future
performance or outcomes. Readers should not place undue reliance on
forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties,
assumptions and other factors that are beyond the Group's control. Given these
risks, uncertainties and assumptions, actual results could differ materially
from any future results expressed or implied by these forward-looking
statements.
These forward-looking statements speak only as of the date of this document.
Except as required by any applicable law or regulation, the Group expressly
disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein to reflect any
change in the Group's expectations with regard thereto or any change in
events, conditions, or circumstances on which any such statement is based.
No assurance can be given that the forward-looking statements in this document
will be realised. Past performance cannot be relied on as a guide to future
performance.
This document does not contain or comprise profit forecasts, investment,
accounting, legal, regulatory or tax advice nor is it an invitation for you to
enter into any transaction. You are advised to exercise your own independent
judgement (with the advice of your professional advisers as necessary) with
respect to the risks and consequences of any matter contained herein.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCBBBDBSSGDGUU
Copyright 2019 Regulatory News Service, all rights reserved